Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | M.-H. Tsai et al., Oncotarget, 2017, 8 (6): 10238-10254 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | K. M. Heppner et al., Diabetes, Jan 2014; 63: 122 - 131 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | V. Ravarotto, PhD Thesis, 2018, Universita degli Studi di Padova | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | Z. Li et al., Nature Microbiology, 2019 , 4: 2475–2486, doi.org/10.1038/s41564-019-0546-y | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Breit et al., J. Biol. Chem., Dec 2006; 281: 37447 - 37456 | Link | |
HEK293 (s) |
Human embryonic kidney cell line (suspension) | ATCC CRL-1573 | Human | urinary system | cell line | suspension | plasmid | Metafectene | application note | ![]() |
|||
HEK293 (s) |
Human embryonic kidney cell line (suspension) | ATCC CRL-1573 | Human | urinary system | cell line | suspension | plasmid | Metafectene | application note | ![]() |
|||
HEK293 EBNA |
Human embryonic kidney cell line stably expressing Epstein-Barr viral nuclear antigen (EBNA) (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. Granato et al., J. Virol., Nov 2014; 88: 12715 - 12726. | Link | |||
HEK293 EBNA1 |
Human embryonic kidney cell line stably expressing Epstein-Barr viral nuclear antigen 1 (EBNA1) (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | O. Gires et al., Anticancer Res, Nov 2004; 24: 3715 - 3722 | Link | ||
HEK293-D2089 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | V. Mordasini et al., Oncotarget, 2017, 8 ( 4): 6461-6474 | Link | ||
HEK293-rB95.8 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | J. Rac et al., PLoS ONE, 2015, 10(4): e0123645; doi:10.1371/journal.pone.0123645 | Link | ||
HEK293-rB95.8 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Rac et al., PLoS ONE, 2015, 10(4): e0123645; doi:10.1371/journal.pone.0123645 | Link | ||
HEK293N |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | T. Bourquard et al., J. Immunol., 2018, ji1701722, DOI: https://doi.org/10.4049/jimmunol.1701722 | ||||
HEK293TN |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HEK293TN |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | F. Walter, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Mahmoodi et al., IET Nanobiotechnol., 2017, 11 (8): 995-1004 | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | C. Stretton et al., Biochem. J., Sep 2015; 470: 207 - 221 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | Z. Knust et al., Infect. Immun., May 2009; 77: 1835 - 1841 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | H. Tanaka et al., FEBS Journal, 2016, 283: 662-677; doi:10.1111/febs.13618 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | S. W. Lee et al., EMBO J., Nov 2012; 31: 4441 - 4452 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | K. Wethmar et al., Oncogene, 2016, 35,1736-1742; doi:10.1038/onc.2015.233 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. G. Theis et al., PNAS, Aug 2004; 101: 11221 - 11226 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. Jennelle et al., J. Biol. Chem., Oct 2014; 289: 28870 - 28884. | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. T. Jennelle, Dissertation, 2013, George Washington University | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | S. Duvezin-Caubet et al., J. Biol. Chem., Dec 2006; 281: 37972 - 37979. | Link |